4
Changes in Ownership
Aprea Therapeutics, Inc. Filed Acc 0001140361-21-006738
SVP, Chief Medical Officer acquired 108,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Attar Eyal C. SVP, Chief Medical Officer | 2021-02-25 | Grant or award | +33,000 | 33,000 | D: show line 1 in the form | ||
| Attar Eyal C. SVP, Chief Medical Officer | 2021-02-25 | Grant or award | +75,000 | 108,000 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Attar Eyal C. SVP, Chief Medical Officer | 2021-02-25 | Grant or award · Stock Option (right to Buy) | +143,000 | 143,000 | D: show line 3 in the form |
Loading xslF345X03/form4.xml…